TACROLIMUS CAPSULES
Drug
Astellas Pharma Inc
Total Payments
$32,909
Transactions
18
Doctors
3
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $32,909 | 18 | 3 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $22,739 | 10 | 69.1% |
| Consulting Fee | $9,990 | 2 | 30.4% |
| Food and Beverage | $180.08 | 6 | 0.5% |
Ad
Manufacturing Companies
- Astellas Pharma Inc $32,909
Product Information
- Type Drug
- Total Payments $32,909
- Total Doctors 3
- Transactions 18
About TACROLIMUS CAPSULES
TACROLIMUS CAPSULES is a drug associated with $32,909 in payments to 3 healthcare providers, recorded across 18 transactions in the CMS Open Payments database. The primary manufacturer is Astellas Pharma Inc.
Payment data is available from 2018 to 2018. In 2018, $32,909 was paid across 18 transactions to 3 doctors.
The most common payment nature for TACROLIMUS CAPSULES is "Travel and Lodging" ($22,739, 69.1% of total).